Alexander Adibekian, PhD, is a Professor in the Department of Chemistry at the University of Illinois Chicago (UIC). He joined UIC in 2022. Broadly speaking, his lab works at the interface of synthetic chemistry, biochemistry and proteomics. They aim to develop chemical tools and mass spectrometry-based platforms for chemoproteomics-enabled drug target identification and anticancer drug discovery, focusing specifically on proteins of high therapeutic promise for cancer treatment that are currently considered “undruggable.” He has co-authored over 80 publications, including numerous publications in the Journal of the American Chemical Society and Nature sub-journals.
“At the heart of our research lies a commitment to developing innovative chemical tools and platforms that have the potential to transform the landscape of cancer treatment, focusing on unlocking the therapeutic promise of proteins once deemed ‘undruggable.’ Our goal is to bring hope and new possibilities to those battling this relentless disease.”